A Ray of hope

Cytotron is new gentle safe non-invasive hope for millions of cancer tumor patients faced with death or the dreaded side effects of conventional treatments such as chemotherapy, radiotherapy and surgery.

Arresting cell growth with RFQMR

RFQMR technology utilizes a totally different approach compared to conventional cancer treatments. Instead of the very high frequency ionizing radiation used in radiotherapy RFQMR uses radio or sub-radio frequency, low power, non-ionizing, non thermal electromagnetic waves.

The main concern of the therapy is not the immediate destruction of the cancer cells, but rather with the help of the small amount of energy provided to the cell to stop the DNA's uncontrolled mitosis, put the cell in a vegetative state and in time through apoptosis mechanism let the body get rid of the cancerous cells in a controlled fashion.

What results have been obtained with Cytotron?
A phase 1 clinical study has been held at the Institute of Aerospace Medicine in India between 2004 and 2006 on more than 100 terminal cancer patients. All patients were undergone all possible conventional interventions such as chemo, radiotherapy or surgery prior to RFQMR and yet the disease cannot be controlled and they are supposed to die within a few days to few months due to cancer. Out of such patients :

There is a 90% symptomatic relief (such as ease of pain, stop using pain killers, no more weight loss etc)
In most of the patients the tumor progression is stopped or reversed
More than 60% survived more than 1 year
More than 35 % went back to normal lives and living disease free for 2 years

As all of those patients are where terminal cases that had exhausted all other treatments, the outcomes of the Cytotron therapy is outstanding. It is believed that in patients who are in a non-terminal situation (in better overall condition, with stronger immune system and has not been subject to the toxic conventional therapies with side effects) the efficacy of Cytotron will be even more pronounced.

Cytotron Cancer FAQ

How many cancer patients have been treated with Cytoton?
The Cytotron treatment has been used on hundreds of cancer / malignant tumor patients.

How effective is RFQMR for Cancer?

Preliminary study on terminal cancer patients reported that tumor progression stopped or reversed in most patients - 80% had pain relief, 60% survived beyond expectation and 35 % were alive and disease free after 2 years and many even went back to normal activity. We consider this as an outstanding result as all these patients were declared terminal cancer patients and not expected to live long. In early stages better result are expected.

What cancers can be treated with Cytotron?

Cytotron can treat all tumors such as brain, breast, cervix, bladder, colon, rectum, lymphomas, liver, lung, ovary, pancreas, kidney, stomach, uterus, prostate, etc. both fro primary tumors and for metastasis

Is Cytotron possible along with other treatments?

Yes, Cytotron therapy is possible before, with or after Radiotherapy, Chemotherapy, Surgery, etc. In patients who have surgery etc. before Cytotron we suggest having a Cytotron protocol MRI before the treatments to enable Cytotron dose planning for treatment to decrease the chance of recurrence.

What tests are required before Cytotron therapy?

MRI, CT or PET-CT, X-ray, laboratory tests etc are required depending on the type of cancer.

How does the patient know that he is better?

Patients are expected to have better quality of life, feel better, have pain relief, eat better and feel more energetic. Pre and post Cytotron MRI can document the tumor to become static and stop growing. Follow up MRIs should show decrease of tumor mass.

MRI before and after Cytotron

What if Cytotron fails or there is a recurrence?

If Cytotron fails it can be repeated or other treatment options like surgery, chemotherapy and Radiotherapy tried.

How does RFQMR work in Tissue Degeneration of the tumor?
In Degenerative RFQMR, like in the application of destruction of the tumor in a cancer patient, it is thought that the chromosomes, following the messages received as a result of the variations of potential (-70 to -90mV normal, -40 to -60 when infected, -20 to -30 in cancer and 0 when dead) in the cytoplasmic membrane, activate through electromechanical effects (stress responsive), the emission of messages by the genes that regulate cell dynamics for normal cell functions or for the mitochondrial activities for ATP production.
It is supposed that the excessive production of ATP is related to an alteration of the glycoproteinic sensors present on the mitochondrion membrane with consequent lowering of the impedance that in turn does not discriminate between the signals in frequency and activates the production of ATP in an almost continual way. The cancer cell would therefore go into mitosis due to the excess of ATP. RFQMR fields are used to act on the mitochondrial membrane, increasing the impedance of the glycoproteinic sensors through the lengthening of the polyglycidic chain. The spin of the RFQMR field is used to interfere with the communications between the genes and the protoplasmic glycoproteinic complexes involved in the promotion of cell mitosis.
By this the impedance of the mitochondrial membrane to the messages coming from the genes increase with the RFQMR treatment and with increase in the malignancy (the highest impedance for undifferentiated tumors). This is related to a greater alteration of the sensors of the undifferentiated tumors and therefore to their greater predisposition to the bond with polyglycidic chains. The undifferentiated cancer cells, because of the high impedance induced on the mitochondrial membrane by the RFQMR treatment, it stops producing ATP and therefore 'possibly' enter into apoptosis. Following the treatment the differentiated cancer cells have an impedance which is still sensitive to some messages coming from the chromosomes promoting the normal production of ATP, so these cells change their state of mitosis; however, they continue to live in a quiescent state (vegetative form of life). The normal cells are not influenced by the RFQMR radiation treatment as the impedance of their mitochondrial sensors is not modified and remain sensitive to messages that arrive from the chromosomes for the activation of the ATP synthesis.

Are not surgery, radiotherapy and chemotherapy good treatment options?

As there is no 100 percent successful treatment for cancer all possible treatments should be adopted. Cytotron is a good safe treatment option and should be tried where ever possible. It can be used along with these or other methods as it's mode of action is totally different.

 What are the advantages of Cytotron therapy?

Cytotron Therapy has the following advantages:
* Purely external with beam of rays.
* No anesthesia, cut, scar, blood transfusion.
* No pain of treatment.
* Usually no hospitalization.
* No treatment complications or infection.
* Possible in surgery unfit patients.
* Well accepted by aware doctors and patients
* Cost effective.

Is Cytotron still experimental?

No, Cytotron to treat Musculoskeletal Disorders and terminal Cancer patients is not experimental as all required technical, safety and clinical requirements have been fulfilled and results published.

 What is the present status of Cytotron therapy?

Cytotron has international patent manufactured in compliance with ISO 9001:2000 and ISO 13485:2003. It has obtained CE Certificate marking European Conformity for safety, public health and consumer protection and has qualified for CMDCAS, Canada's Health regulatory requirements making it acceptable in Europe and Canada for tissue regeneration and degeneration.

Research result of treatment of Cancer with Cytotron: